EQS-Adhoc: Marinomed Biotech AG begins reviewing strategic options for the Marinosolv platform
EQS-Ad-hoc: Marinomed Biotech AG / Key word(s): Strategic Company Decision
Marinomed Biotech AG begins reviewing strategic options for the Marinosolv
platform
06-Oct-2025 / 14:56 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the
Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS
Group.
The issuer is solely responsible for the content of this announcement.
══════════════════════════════════════════════════════════════════════════
Ad hoc announcement
Marinomed Biotech AG!-->…